Edition:
United States

Tekla Life Sciences Investors (HQL.N)

HQL.N on New York Stock Exchange

18.91USD
27 Feb 2017
Change (% chg)

$0.56 (+3.05%)
Prev Close
$18.35
Open
$18.37
Day's High
$18.92
Day's Low
$18.37
Volume
16,523
Avg. Vol
24,868
52-wk High
$19.98
52-wk Low
$15.86

HQL.N

Chart for HQL.N

About

Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed... (more)
No analyst recommendations are available for HQL.N.

Overall

Beta: 1.56
Market Cap(Mil.): $377.92
Shares Outstanding(Mil.): 20.12
Dividend: 0.36
Yield (%): 10.38

Financials

  HQL.N Industry Sector
P/E (TTM): -- 10.75 19.42
EPS (TTM): -5.96 -- --
ROI: -26.79 0.42 0.40
ROE: -26.79 0.81 15.29

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.